Skip to main content
Equibles
SGHT logo

SGHT · Sight Sciences, Inc. · Metrics

Track SGHT — free

Use SGHT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SGHT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.08 +0.32 (+3.28%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$555.51M
Shares
55.58M
Volume · Nov 6 576.41K Avg daily vol (3M) 300.98K

SGHT metrics

85 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.08
Market cap
$555.51M

Price action

23 metrics
Price change (1W)
+2.0%
Price change (30D)
+15.2%
Price change (3M)
+37.7%
Price change (6M)
+84.5%
Price change (YTD)
+23.1%
Price change (1Y)
+94.0%
Trailing year
Price change (5Y)
-61.2%
52-week high
$9.76
52-week low
$3.45
Change from 52-week high
+0.0%
Change from 52-week low
+182.9%
Annualized volatility
75.7%
Annualized volatility (3M)
70.2%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.5
RSI (14D)
64.2
Price vs SMA 50
+12.4%
Price vs SMA 200
+61.4%
Avg volume (3M)
304,084
Relative volume
3.5
Average dollar volume
$2.62M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
55.58M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.9×
reciprocal yield 17.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.3×
reciprocal yield 15.9%
P / book
11.3
reciprocal yield 8.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.2×
reciprocal yield 44.9%
EV / revenue historical average (5Y)
2.7×
reciprocal yield 36.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
87.7%
Operating margin
-29.5%
Trailing 12 months
Net margin
-32.1%
Gross profit (TTM)
$77.56M
Operating profit (TTM)
−$26.10M
Net income (TTM)
−$28.40M
Trailing 12 months
Diluted EPS (TTM)
$-0.51
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.63
Gross profit per diluted share (TTM)
$1.43
Operating profit per diluted share (TTM)
$-0.48
EBITDA per diluted share (TTM)
$-0.47
Net income per diluted share (TTM)
$-0.52
Operating cash flow per diluted share (TTM)
$-0.31
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.19
Stock compensation per diluted share (TTM)
$0.21
Book value per share
$1.20

Growth

11 metrics
Revenue growth YoY
+25.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$88.39M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.2%
Year over year · more shares
Revenue CAGR (3Y)
+2.7%
Revenue CAGR (5Y)
+22.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-57.8%
Return on assets
-27.1%
Debt / equity
0.8
Current ratio
5.0
EBITDA (TTM)
−$25.68M
Free cash flow (TTM)
—
Quick ratio
4.7
Interest coverage
-5.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$36.37M
Latest balance sheet
Cash & equivalents
$77.40M
Total assets
$104.95M
Total debt
$41.03M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$16.92M
Capital expenditures (TTM)
$93,000
R&D (TTM)
$10.20M
SG&A (TTM)
$93.46M
Stock compensation (TTM)
$11.30M
R&D / revenue
11.5%
Stock compensation / revenue
12.8%

Ownership (13F)

9 metrics
13F filers
112
13F filer change QoQ
-2
Institutional ownership
39.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
16.9%
Private-fund adviser ownership
16.1%
Active holders' share change QoQ
-5.7%
Holder tenure
8.5
Price vs estimated holder cost
-22.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.0%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$652,777
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1531177 CUSIP 82657M105 13F (30d) 50 filings 38 filers Visit website Investor relations